Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) FCF Margin Growth (1y) (2010 - 2026)

Analysis

Bio-Rad Laboratories (BIO) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn 379.00
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn 183.00
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn 847.00
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn -537.00
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn 876.00
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn -237.00
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn -62.00
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn 164.00
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn 86.00
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn 600.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -62.00
Mar 31, 2026 -312.00
Dec 31, 2025 500.00
Sep 30, 2025 -533.00
Jun 30, 2025 220.00
Mar 31, 2025 1,147.00
Dec 31, 2024 649.00
Sep 30, 2024 1,051.00
Jun 30, 2024 -65.00
Mar 31, 2024 -437.00
Dec 31, 2023 -45.00
Sep 30, 2023 1,092.00
Jun 30, 2023 411.00
Mar 31, 2023 673.00
Dec 31, 2022 -952.00
Sep 30, 2022 -2,864.00
Jun 30, 2022 -1,313.00
Mar 31, 2022 -1,045.00
Dec 31, 2021 -1,543.00
Sep 30, 2021 833.00